The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue ...

The global DNA methylation market size was valued at US$ 1.9 Bn in 2025 and is projected to reach US$ 7.7 Bn by 2036, growing ...

A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing ...

The global automated nucleic acid extraction market size was valued at US$ 3.6 Bn in 2025 and is projected to reach US$ 11.7 ...

There are hundreds of cell types in the human body, each with a specific role spelled out in their DNA. In theory, all it ...

A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing challenge of simultaneously achieving high sensitivity, broad coverage, and simple ...

Preliminary 2025 thyroid testing revenue grew 21% over prior yearInitial 2026 guidance of 16% growth in thyroid testing revenue All preferred ...

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

New data show cancer survival has reached a record high — nearly 70% of patients now live at least five years after diagnosis ...

Carbon-based electrochemical biosensors are gaining prominence as highly versatile platforms for non-invasive cancer ...

Researchers at National Taiwan University have developed a modular platform to reprogram tumor-derived extracellular vesicles ...

The accurate early detection and precise localization of diseases remain pivotal challenges in modern medicine. Traditional diagnostic methods often grapple ...